DIFELIKEFALIN
Body System:
Manner of administration:Injection
Restriction
Indication: Moderate to severe pruritus (itching) associated with chronic kidney disease
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 12 | # of repeats: 5 | DPMQ: $570.48 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Korsuva | |||||
Body System:
Manner of administration:Injection
Restriction
Indication: Moderate to severe pruritus (itching) associated with chronic kidney disease
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 12 | # of repeats: 2 | DPMQ: $570.48 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Korsuva | |||||
Body System:
Manner of administration:Injection
Restriction
Indication: Moderate to severe pruritus (itching) associated with chronic kidney disease
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 12 | # of repeats: 2 | DPMQ: $540.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Korsuva | |||||
Body System:
Manner of administration:Injection
Restriction
Indication: Moderate to severe pruritus (itching) associated with chronic kidney disease
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 12 | # of repeats: 5 | DPMQ: $540.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Korsuva | |||||